Background: To identify computer extracted in vivo dynamic contrast enhanced (DCE) MRI markers associated with quantitative histomorphometric (QH) characteristics of microvessels and Gleason scores (GS) in prostate cancer. Methods: This study considered retrospective data from 23 biopsy confirmed prostate cancer patients who underwent 3 Tesla multiparametric MRI before radical prostatectomy (RP). Representative slices from RP specimens were stained with vascular marker CD31. Tumor extent was mapped from RP sections onto DCE MRI using nonlinear registration methods. Seventy-seven microvessel QH features and 18 DCE MRI kinetic features were extracted and evaluated for their ability to distinguish low from intermediate and high GS. The effect of temporal sampling on kinetic features was assessed and correlations between those robust to temporal resolution and microvessel features discriminative of GS were examined. Results: A total of 12 microvessel architectural features were discriminative of low and intermediate/high grade tumors with area under the receiver operating characteristic curve (AUC) > 0.7. These features were most highly correlated with mean washout gradient (WG) (max rho 5 20.62). Independent analysis revealed WG to be moderately robust to temporal resolution (intraclass correlation coefficient [ICC] 5 0.63) and WG variance, which was poorly correlated with microvessel features, to be predictive of low grade tumors (AUC 5 0.77). Enhancement ratio was the most robust (ICC 5 0.96) and discriminative (AUC 5 0.78) kinetic feature but was moderately correlated with microvessel features (max rho 5 20.52). Conclusion: Computer extracted features of prostate DCE MRI appear to be correlated with microvessel architecture and may be discriminative of low versus intermediate and high GS.
O verdiagnosis and overtreatment of prostate cancer 1, 2 has led to the growing interest in adopting conservative disease management strategies such as active surveillance. 3 However, success of such strategies rely on the ability to selectively recruit patients with low-risk tumors, where low-risk refers to low likelihood of death on account of prostate cancer. 4 Although pathology is the clinical standard for prostate cancer risk assessment, with Gleason scores and microvessel density (MVD) being some of the most well established surrogates of outcome, [5] [6] [7] pathological criteria for in vivo risk determination is significantly limited by biopsy sampling errors. 8, 9 Multiparametric (MP) MRI has emerged as a promising modality for prostate cancer diagnosis given its high sensitivity and specificity for detection of clinically significant prostate cancer in vivo. 5 Among the MP-MRI sequences, dynamic contrast enhanced (DCE) MRI has shown promise in its ability to assess tumor aggressiveness. 10, 11 Growing tumors comprising large number of leaky microvessels are expected to show increased enhancement as well as faster contrast uptake and washout as compared to indolent tumors. Previous studies have shown associations between various kinetic and pharmacokinetic features and Gleason scores. Most recently, Vos et al. 11 found statistics of washin, washout rate as well as pharmacokinetic parameters, K trans and K ep , to be significantly different in patients with low and high Gleason scores. However, Gleason grade for an average prostate cancer patient spans a narrow range between 6 and 7, where scores 6 are considered low risk, scores of 7 are considered intermediate risk and scores > 7 are considered high risk. 12 Provided that active surveillance is recommended for low risk prostate cancer, 13, 14 it is necessary to identify markers that distinguish low from both intermediate and high risk tumors. In this work, we, therefore, consider a patient population with Gleason scores between 6 and 8, the range where each increment in score results in a change in risk categorization, and seek DCE MRI markers capable of distinguishing low risk (Gleason score 6) from intermediate and high risk (Gleason score > 6) prostate cancer within this population. However, roughly 49% of the prostate cancer population comprises of moderately differentiated, intermediate grade tumors. 15 which can have up to three-fold differences in the risk of mortality. 16 Therefore, Gleason score, and consequently its MRI correlate, is likely to be insufficient in determining candidates for active surveillance. Bostwick et al. 17 found that combining Gleason scores and preoperative prostate specific antigen with microvessel density improved their ability to predict extraprostatic extension, a surrogate of outcome. In this work, we therefore additionally explore correlations between quantitative DCE MRI characteristics and microvessel attributes to identify in vivo markers of prostate cancer risk. Microvessel morphology. 18 and microvessel density (MVD) are known to be associated with prostate cancer risk. 5, 6 MVD is pathologically determined as the number of microvessels per unit area within hotspots, or regions of high MVD within the tumor. Determination of the location and size of these hotspots is subjective due to lack of standard, established criteria for identifying microvessel hotspots. 19 As such, a recent attempt at identifying imaging correlates of MVD to discover in vivo DCE MRI markers of prostate cancer presence relied on computing MVD within local neighborhood around each pixel. 20 Tretiakova et al. 19 qualitatively demonstrated that differences in spatial distribution of microvessels has contributed to the perceived differences in MVD between tumor and benign tissues despite the similarities in total microvessel counts in the two tissue types. Measures of microvessel arrangement may therefore serve as more direct and objective alternatives to MVD. As depicted with representative image patches in Figure 4 , tumors assigned the same Gleason score may display different microvessel configurations. To capture such differences, we attempt to model the spatial distribution of microvessels using quantitative histomorphometry (QH), which uses computerized image based feature analysis to model the appearance of disease on digitized histopathology. 21, 22 As previous work has shown that MVD is associated with Gleason grades. 23 we individually assess each microvessel QH feature in terms of its ability to predict low versus intermediate and high Gleason grades to retain the most informative microvessel QH features for subsequent correlative analysis with in vivo DCE MRI. The purpose of this study is to identify in vivo DCE MRI markers of prostate cancer risk by examining the correlations between kinetic features and pathological prognostic markers, Gleason score and microvessel architecture. Figure  1 shows our radiology-pathology correlation framework which uses image registration, segmentation, and feature extraction methods to study associations between radiologic and pathologic attributes within spatially aligned regions of interest.
Materials and Methods

Dataset Description
This retrospective study was approved by the Institutional Review Board, which waived informed consent. Subjects imaged by 3 Tesla (T) DCE MRI and T2w MRI between 2009 and 2011, who subsequently underwent radical prostatectomy at University of Pennsylvania were eligible for this study. A total of 54 subjects were identified. Two cases where DCE MRI did not follow routine protocol were excluded, leaving 52 potential cases. Twenty-three of the 52 cases were selected and formed our study population (age range: 46-69 years; mean age: 59.3 years) to include a spectrum of cases with different Gleason scores.
All MRI studies were performed on a 3 Tesla MRI scanner (VerioV C , Siemens, Erlangen, Germany) using a dedicated endorectal coil (MedradV C , Pittsburgh, PA). Axial T1 and T2w imaging was performed with 3-mm slice thickness and 1-mm gap. Prostate quadrants were stitched into pseudo whole-mount sections using Histostitcher, 24, 25 an interactive program that assembles digitized histologic fragments into a contiguous slice as shown in Figure 2 . At least three corresponding points between adjacent quadrants were manually selected. Transformations required to maximally align these points were then computed, applied, and stored. The same transformations were then reapplied to binary images of quadrant annotations to obtain prostate cancer masks for pseudo whole-mount sections.
To map cancer annotations from reconstructed histologic sections onto the MRI (Fig. 3) , correspondences between T2w MRI, H&E, and CD31 stained slices were identified by expert radiologist and pathologist based on distances between slices and major anatomical landmarks. 26 Subsequently, CD31 stained sections were registered with corresponding T2w MRI slices using thin plate splines (TPS), a landmark based registration method that interpolates the transformation at each voxel such that it (i) maximizes overlap between target and template landmarks, establishing accurate spatial correspondences while (ii) minimizing the bending energy to generate smooth transformations. 27 Manually selected landmarks were used to align prostate boundaries and visible internal structures (such as urethra) between the moving histology image and the target T2w MRI image. T2w MRI volume was resampled and aligned with DCE MRI volume using BRAINS resampling module in three-dimensional 3D Slicer. 28 which allowed for mapping of cancer extent from T2w MRI to DCE MRI.
Microvessel Segmentation and Feature Extraction
Vascular structures expressing CD31 within tumor regions were segmented using Hierarchical Normalized Cuts (HNCut) as shown in Figure 4 . 29 HNCut combines frequency weighted mean shift (FWMS) and normalized cuts (NCut) in a hierarchical manner at multiple resolutions to identify differently stained biomarker regions corresponding to user selected color swatch.
To capture the overall MVD within the tumor, we compute features using the following two definitions of densities: (1) ratio of microvessel area to tumor area (MVD area ), (2) number of microvessels per unit area of tumor (MVD num ). In addition, graph based and nearest neighbor based QH features were computed. Graph based features capture the overall architecture of the structures of interest using graphical constructs while the nearest neighbor 
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Month 2015features seek to capture density in local neighborhoods. To extract graph based features, centroids of segmented CD31 stained microvessels were used as nodes which were connected using Delaunay, Voronoi, and Minimum spanning tree graphs. A total of 24 statistical features, listed in Table 1 , were then extracted from these graphical representations of microvessel distribution. 30 In addition, 24 nearest neighbor (NN) features were extracted by computing statistics of distance to NN around each microvessel and the number of microvessels within a given pixel radius. Another 24 statistical shape features of microvessel area, perimeter, orientation, length of major and minor axes, and eccentricity were included in the analysis, resulting in a total of 77 features.
Experimental Design for Microvessel Feature Selection
Quadratic discriminant analysis (QDA) was applied using leaveone-out cross validation strategy on the entire data cohort to independently evaluate each feature in terms of its ability to distinguish between patients with low grade and intermediate/high grade tumors. For each feature, a QDA classifier was constructed, which enabled the identification of a quadratic surface that optimally separates inputs from different classes. Area under the receiver operating characteristic curve (AUC), accuracy, balanced accuracy, sensitivity, and specificity, were computed to assess classification performance of each feature. Finally, features with an FIGURE 2: Reconstruction of whole-mount prostate sections using HistoStitcher 24, 25 . Sectioned quadrants of surgical specimens (a) are stitched into hemispheres (b), which are then combined to obtain pseudo whole-mount section (pWMHs) that is annotated for cancer (red outline) (c).
FIGURE 3: Histology-MRI co-registration scheme used to map cancer annotations from CD31 stained pseudo whole-mount radical prostatectomy section (a) onto its corresponding T2w (b) and DCE (c) MRI slices. d: Histology is first registered to T2w MRI, following which (e) the transformation needed to align T2 and DCE is learned and (f) re-applied to the T2-transformed histology section to obtain histology-DCE MRI registration.
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AUC > 0.7 were retained for subsequent correlation analysis with DCE MRI.
DCE MRI Feature Extraction
Mapping of cancer extent from histology to DCE MRI presents an opportunity for interrogation of tumor contrast kinetics at per-voxel level. Kinetic curves were computed at each voxel by averaging over a 3 3 3 neighborhood and the following kinetic features were computed: maximum uptake (MU), time to peak (TTP), initial gradient (IG), washout gradient (WG), enhancement (En), enhancement ratio (EnR), initial area under the curve (IAUC) at 30, 60 s, and total area under the curve. Maximum uptake was defined as the maximum signal intensity and time to peak was defined as the time at maximum signal intensity. Initial enhancement was computed as the initial slope of the signal intensity versus time curve while enhancement ratio was the ratio of initial enhancement and maximum uptake. To obtain initial gradient and washout gradient as defined by Chen et al. 10 relative enhancement (RE) curves were obtained where RE(t)
5 (SI(t) post -SI pre )/SI(t) post 3 100. Initial gradient was computed as the slope between 10% and 70% of maximum enhancement and the washout gradient was computed as the slope at the last 60 s of the RE curve. Initial gradient, washout gradient, and initial area under the curve features were calculated by linearly interpolating RE curves. . c,i: Ellipsoids enclosing the microvessels provide measurements of shape such as eccentricity, a measure of circularity, which is depicted by means of ellipsoid color (red 5 ellipse, blue 5 circle). Microvessel architectural features are extracted from graphical representations of microvessel distribution: Voronoi diagram (d,j), Delaunay triangulation (e,k), and minimum spanning tree (f,l).
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Experimental Design for DCE MRI Kinetic Feature Evaluation
The effect of temporal resolution on kinetic features was studied by evaluating the concordance between feature values extracted from the original and temporally downsampled kinetic curves. For this experiment, we considered a subset of the data comprising 5 cases with high temporal resolutions ranging between 8 and 12 s. At each tumor voxel, three temporally downsampled kinetic curves were generated by considering every second, third, and fourth time frame which resulted in curves with temporal sampling of roughly 16, 24, and 32 s. These simulated curves spanned the range of resolutions found in our data cohort. Intraclass correlation coefficient (ICC) was used to estimate the concordance of feature values extracted from the original and downsampled kinetic curves.
In addition, each kinetic feature was evaluated in terms of its ability to distinguish low from intermediate and high grade prostate cancer using the entire data cohort. A QDA classifier was constructed independently for each feature statistic (Table 2) capturing the distribution of feature values over all tumor voxels from each patient. Classification was performed using leave-one-out cross validation strategy to account for the small sample size considered in this work. The resulting AUC was then plotted against ICC to identify kinetic features that are robust to temporal resolution and are predictive of low grade prostate cancer.
Statistical Analysis
Spearman's rank correlation test was used to assess strengths of associations between select kinetic features (ICC > 0.5) and select microvessel features (AUC > 0.7). The test seeks a general monotonic trend without assuming linearity and is robust to outliers. The resulting matrix of pairwise correlation coefficients was visualized as a heatmap, which we term radiohistomorphometric map. Statistical significance of each pairwise correlation was assessed using false discovery rate (FDR) to account for multiple hypothesis testing. 31 All statistical analyses were performed in Matlab (Mathworks, Natick, MA).
Results
Microvessel Features Discriminative of Low From Intermediate and High Grade Prostate Cancer
As shown in Table 2 , QDA classification results revealed 15 microvessel features which were independently able to Of the 12 architectural features, 4 were graphbased features obtained from Delaunay and minimum spanning tree graphs and 8 were measures of local microvessel density based on distance to nearest neighbors and number of nearest neighbors within a given pixel radius around each microvessel. According to the balanced accuracy measure, disorder in the number of nearest neighbors in a 20-pixel radius and mean Delaunay triangle area were the best performing features with balanced accuracies of 0.79. By contrast, the density feature had a lower balanced accuracy of 0.64 whereas the two morphologic features, mean microvessel area and mean microvessel major axis length, had balanced accuracies of 0.64 and 0.68, respectively. Taking into consideration all the evaluation metrics, mean Delaunay triangle area of microvessel architecture appears to be the best performing feature with high AUC, accuracy, balanced accuracy, sensitivity, and specificity. Figure 5 shows the trade-off between feature stability with respect to temporal resolution and discriminability with respect to Gleason scores for all kinetic features. Although variance in initial area under the curve at 60 s (var IAUC 60) appears to be highly discriminative of Gleason scores with an AUC > 0.9, it has low ICC indicating that the feature is highly sensitive to temporal resolution. Mean enhancement ratio, variance washout gradient and variance initial gradient on the other hand have ICC > 0.6 and are predictive of low grade prostate cancer with an AUC > 0.75. 
Stability and Discriminability of DCE MRI Features for Prostate Cancer Risk Assessment
Radiohistomorphometric Maps Associate In Vivo DCE MRI Features With Microvessel Characteristics on CD31 Stained Ex Vivo Pathology
Pairwise correlation between histology and MRI features were examined on per-patient basis, wherein feature statistics were computed within the tumor across all annotated slices for each patient. Figure 6 shows the correlation heatmap of pairwise associations between the 15 microvessel features which were found to have an AUC > 0.7 in predicting low grade tumor and 12 DCE MRI features which were found to be robust to temporal resolution with an ICC > 0.5. As can be seen in Table 2 and Figure 6 , most of the architectural features were maximally and significantly (FDR < 0.05) correlated with mean washout gradient. In particular, mean washout gradient was most highly and significantly correlated with features capturing the average number of nearest neighbors within specified pixel radius (PR) (max rho 5 
Discussion
Overdiagnosis and overtreatment of prostate cancer has contributed to the emerging need for in vivo imaging markers of prostate cancer risk. Identification of such markers may enable selection of suitable candidates for active surveillance, where patients are actively observed and only treated upon signs of disease progression. In this study, we introduced a quantitative image analysis framework for radiology-pathology convergence that allowed us to identify promising DCE MRI markers that were (i) correlated with a subset of quantitative histomorphometric features of microvessels, (ii) discriminative of low versus intermediate/high Gleason scores, and appeared to be (iii) robust to temporal resolution. Challenges in extracting and relating quantitative descriptors of tumor appearance on radiology and pathology were addressed by using automated segmentation, quantitative histomorphometric feature extraction, and image co-registration methods. This study identified promising potential markers, initial enhancement ratio, and washout gradient, the latter of which was previously shown to be discriminative of Gleason scores. 10, 11 While previous work additionally showed associations between Gleason scores and pharmacokinetic features, temporal resolutions of the studies in our data cohort limited us from considering these features as they are known to be sensitive to temporal resolution. 32 The datasets considered in previous work had temporal resolutions of 2 s 10 and 3 s 11 whereas the maximum resolution of the data considered in this study was 8 s. Thus, in addition to constraining our analysis to kinetic features, we also attempted to study feature robustness using temporally downsampled kinetic curves to simulate those extracted at lower temporal resolutions. However, the simulated curves do not take into account changes in spatial resolution that accompany changes in temporal sampling on imaging. As such, we assumed that none of the other image characteristics are significantly affected by changes in temporal resolution. The most commonly used clinical criteria for selection of patients for active surveillance include only patients with GS 6. 33 However, a long-term follow-up study. 34 showed that the 10 and 15 year prostate cancer specific survival rate was 98% and 94%, respectively, for a data cohort that included patients with both low risk (GS 6) This study, however, also had limitations. First, we considered a small data cohort obtained from a larger set of patients who were eligible for this study. Time and budget constraints associated with sectioning, staining, and annotation of radical prostatectomy specimens limited the study to only 23 patients. Second, there is no practical method for assessing registration accuracy at per-voxel level. While attempts were made to minimize errors in the x-y plane by selecting anatomical landmarks visible on both histology and MRI, identifying slice correspondences to ensure accurate mapping in the z plane is a highly challenging task. Furthermore, microvessel features for correlative analysis were selected based on their ability to separate tumors of different Gleason scores due to absence of outcome information. Numerous studies have reported the limitations of Gleason grading system, primarily due to its associated inter-, and intra-observer variability. 36 These limitations are particularly pertinent to tumors with intermediate grades, which form the largest group in this study's data cohort.
In conclusion, this work presented a radiologypathology correlation framework that enabled identification of promising in vivo DCE MRI markers of prostate cancer risk. Future directions of this work include interrogating the imaging markers identified in this study on a larger data cohort to evaluate their ability to predict longer term disease outcome. In addition, we would like to explore features from other MP-MRI protocols such as T2w MRI and diffusion weighted imaging (DWI) that may be informative of tumor aggressiveness by the virtue of their correlation with other histologic and immunohistochemical biomarkers of prostate cancer risk.
